JAMES M FRATES

CIK 1235598 · Chief Financial Officer · last filed 2026-03-09

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$15.98M

Companies

3

Total Filings

210

Lifetime Open-Market Net

-$42.52M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AMLX Chief Financial Officer 361,628 $14.59 $5.28M -$3.22M 23 2026-03-09
Sage Therapeutics, Inc. (SAGE) Delisted Director 1,810 $8.68 $15.7K -$4.48M 21 2025-07-31
ALKS SVP, Alks Inc; CFO ALKS 241,828 $44.28 $10.71M -$34.81M 166 2020-05-14

Recent Filings · Page 6 of 21

210 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2018-05-08 Sage Therapeutics, Inc. (SAGE) Delisted Mixed -$1.02M EDGAR
2018-03-05 ALKS Mixed +4,958 -$137.9K EDGAR
2018-02-28 ALKS Mixed +1,851 -$45.0K EDGAR
2018-02-21 ALKS Mixed +2,071 -$62.5K EDGAR
2017-11-30 ALKS Mixed -$800.0K EDGAR
2017-11-09 ALKS Mixed −2,000 -$738.8K EDGAR
2017-06-08 Sage Therapeutics, Inc. (SAGE) Delisted Grant (A) $0 EDGAR
2017-05-30 ALKS Mixed +1,323 -$67.9K EDGAR
2017-03-07 ALKS Mixed -$1.06M EDGAR
2017-03-06 ALKS Mixed +1,899 -$55.7K EDGAR
Showing 5160 of 210
Page 6 of 21
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.